☆ 4.7 Article

Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study

INTERNATIONAL JOURNAL OF CANCER (2023)

Related references

Note: Only part of the references are listed.

Review Urology & Nephrology

Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis

Jing Miao et al.

Summary: Immune checkpoint inhibitors (ICIs) have greatly improved cancer therapy outcomes, but they can also cause immune-related adverse events (irAEs). ICI-associated acute interstitial nephritis (ICI-AIN) is a common irAE that leads to acute kidney injury (AKI) in a small percentage of patients. The pathophysiology of ICI-AIN, particularly its interaction with AIN-inducible drugs like proton pump inhibitors (PPIs), is not yet fully understood. This review aims to discuss the incidence, mechanisms, clinical presentation, diagnosis, and management of PPI-related AIN in the context of ICI therapy.

CLINICAL KIDNEY JOURNAL (2023)

Add to Collection

Article Oncology

Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy

Megan L. Baker et al.

Summary: In patients receiving ICI therapy, AKI is common and associated with higher mortality, however, AKI related to AIN is associated with lower mortality.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Urology & Nephrology

Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study

Alexandre O. Gerard et al.

Summary: Immune checkpoint inhibitors (ICIs) can lead to immune-related adverse events (IRAEs), including acute tubulointerstitial nephritis. This study compared patients with renal IRAEs (ICI-AKI) to those with other IRAEs and found that ICI-AKI patients were older, had a higher prevalence of chronic kidney disease, and were more likely to be treated with fluindione, NSAIDs, or PPIs.

CLINICAL KIDNEY JOURNAL (2022)

Add to Collection

Article Urology & Nephrology

Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience

Diana Oleas et al.

Summary: This study highlights the occurrence of AIN in patients with solid organ metastatic malignancies treated with CPIs, with the kidney being a commonly affected organ. The majority of patients showed improvement in kidney function with steroid treatment, indicating a favorable response to this type of toxicity.

CLINICAL KIDNEY JOURNAL (2021)

Add to Collection

Article Transplantation

Acute kidney injury in patients treated with anti-programmed death receptor-1 for advanced melanoma: a real-life study in a single-centre cohort

Claire Stein et al.

Summary: The study evaluated the incidence, risk factors, and causes of acute kidney injury (AKI) in patients with advanced melanoma treated with anti-PD1 therapy. AKI was mainly prerenal and associated with use of RAASi, CKD, and cumulative doses of anti-PD1. Notably, PPI and corticosteroids were linked to poorer survival outcomes, while overweight/obesity were protective factors.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Add to Collection

Article Urology & Nephrology

Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study

Yoshinosuke Shimamura et al.

Summary: The study revealed that the use of Pembrolizumab and the presence of liver diseases are associated with a higher risk of developing acute kidney injury (ICPi-AKI) with immune checkpoint inhibitors (ICPis), but ICPi-AKI does not affect mortality rates.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)

Add to Collection

Article Oncology

Acute kidney injury in patients treated with immune checkpoint inhibitors

Shruti Gupta et al.

Summary: Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) is an important toxicity among cancer patients. Impaired renal function at baseline, PPI use, and extrarenal irAEs were associated with a higher risk of ICPi-AKI. Two-thirds of patients experienced renal recovery following ICPi-AKI, with corticosteroid treatment associated with improved recovery.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Medicine, General & Internal

Immune checkpoint inhibitors in melanoma

Matteo S Carlino et al.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study

Marije S. Koks et al.

Summary: This study aimed to investigate the incidence, risk factors, renal outcomes, and mortality of AKI in patients receiving checkpoint inhibitors for cancer treatment. The study found that one third of AKI cases were associated with checkpoint inhibitors, with an overall incidence of 14.2%. Checkpoint inhibitor-associated AKI was mostly low-grade and resulted in persistent renal dysfunction in approximately 40% of patients. Patients with all-cause AKI had a twofold increased mortality risk, but checkpoint inhibitor-associated AKI did not increase mortality.

PLOS ONE (2021)

Add to Collection

Article Urology & Nephrology

Immunotherapy-Related Acute Kidney Injury

Sandhya Manohar et al.

Summary: Immunotherapy revolutionizes oncology by augmenting the immune system to eradicate cancer, but comes with unique adverse effects such as nephrotoxicity. This review summarizes the current use of immunotherapies, their kidney-related toxicities, pathophysiology, and management.

ADVANCES IN CHRONIC KIDNEY DISEASE (2021)

Add to Collection

Article Urology & Nephrology

Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study

Frank B. Cortazar et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Existing Data Sources in Clinical Epidemiology: Laboratory Information System Databases in Denmark

Johan Frederik Hakonsen Arendt et al.

CLINICAL EPIDEMIOLOGY (2020)

Add to Collection

Article Oncology

Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

Alejandro Meraz-Munoz et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Review Immunology

Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors

Juwhan Choi et al.

IMMUNE NETWORK (2020)

Add to Collection

Article Oncology

Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution

Ammar Sukari et al.

ANTICANCER RESEARCH (2019)

Add to Collection

Review Public, Environmental & Occupational Health

The Danish health care system and epidemiological research: from health care contacts to database records

Morten Schmidt et al.

CLINICAL EPIDEMIOLOGY (2019)

Add to Collection

Article Urology & Nephrology

The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors

Harish Seethapathy et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Add to Collection

Article Chemistry, Medicinal

Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies

Yi Yang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2017)

Add to Collection

Review Urology & Nephrology

PPIs and kidney disease: from AIN to CKD

Dennis G. Moledina et al.

JOURNAL OF NEPHROLOGY (2016)

Add to Collection

Article Medicine, General & Internal

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

Benjamin Lazarus et al.

JAMA INTERNAL MEDICINE (2016)

Add to Collection

Article Gastroenterology & Hepatology

Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study

Anton Pottegard et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)

Add to Collection

Review Public, Environmental & Occupational Health

The Danish National Patient Registry: a review of content, data quality, and research potential

Morten Schmidt et al.

CLINICAL EPIDEMIOLOGY (2015)

Add to Collection

Review Public, Environmental & Occupational Health

The Danish Civil Registration System as a tool in epidemiology

Morten Schmidt et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)

Add to Collection

Article Urology & Nephrology

A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use

Mei-Ling Blank et al.

KIDNEY INTERNATIONAL (2014)

Add to Collection

Article Urology & Nephrology

Proton pump inhibitors and acute kidney injury: a nested case-control study

Donald G. Klepser et al.

BMC NEPHROLOGY (2013)

Add to Collection

Article Public, Environmental & Occupational Health

Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark

Grann et al.

Clinical Epidemiology (2011)

Add to Collection

Review Urology & Nephrology

Acute interstitial nephritis

Manuel Praga et al.

KIDNEY INTERNATIONAL (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.